QIAGEN (QGEN)
(Delayed Data from NYSE)
$40.58 USD
-0.12 (-0.30%)
Updated Jul 3, 2024 01:00 PM ET
2-Buy of 5 2
B Value D Growth C Momentum D VGM
Brokerage Reports
QIAGEN N.V. [QGEN]
Reports for Purchase
Showing records 1 - 20 ( 238 total )
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Company: QIAGEN N.V.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department